Amgen Q2 Adj. EPS $6.29 Beats $5.62 Estimate, Sales $10.054B Beat $9.421B Estimate
Amgen (NASDAQ:AMGN) reported quarterly earnings of $6.29 per share which beat the analyst consensus estimate of $5.62 by 11.92 percent. This is a 4.49 percent increase over earnings of $6.02 per share from the same period last year. The company reported quarterly sales of $10.054 billion which beat the analyst consensus estimate of $9.421 billion by 6.72 percent. This is a 9.53 percent increase over sales of $9.179 billion the same period last year.
Login to comment